Literature DB >> 11369080

Modeling transdermal drug release.

Y N Kalia1, R H Guy.   

Abstract

The stratum corneum forms the outermost layer of the skin and is essentially a multilamellar lipid milieu punctuated by protein-filled corneocytes that augment membrane integrity and significantly increase membrane tortuosity. The lipophilic character of the stratum corneum, coupled with its intrinsic tortuosity, ensure that it almost always provides the principal barrier to the entry of drug molecules into the organism; the only exceptions being highly lipophilic species which might encounter problems at the stratum corneum-viable epidermis interface where they must partition into a predominantly aqueous environment. Drugs can be administered either as suspensions or as solutions and the formulation can range in complexity from a gel or an ointment to a multilayer transdermal patch. In this review we describe the theoretical principles used to describe transdermal release and we show that relatively simple membrane transport models based on the appropriate solution to Fick's second law of diffusion can be used to explain drug release kinetics into this complex biological membrane.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369080     DOI: 10.1016/s0169-409x(01)00113-2

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  23 in total

1.  The Delivery of α1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore.

Authors:  Srinu Tumpara; Beatriz Martinez-Delgado; Gema Gomez-Mariano; Bin Liu; David S DeLuca; Elena Korenbaum; Danny Jonigk; Frank Jugert; Florian M Wurm; Maria J Wurm; Tobias Welte; Sabina Janciauskiene
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

2.  Preparation and in vitro evaluation of a new fentanyl patch based on functional and non-functional pressure sensitive adhesives.

Authors:  Seyed Mojtaba Taghizadeh; Arezou Soroushnia; Fatemeh Mohamadnia
Journal:  AAPS PharmSciTech       Date:  2010-02-25       Impact factor: 3.246

3.  Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs.

Authors:  Jelena Djordjevic; Bozena Michniak; Kathryn E Uhrich
Journal:  AAPS PharmSci       Date:  2003-10-16

4.  Diffusion properties of inkjet printed ionic self-assembling polyelectrolyte hydrogels.

Authors:  Skander Limem; Paul Calvert
Journal:  J Mater Chem B       Date:  2015-05-11       Impact factor: 6.331

Review 5.  Potential new methods for antiepileptic drug delivery.

Authors:  Robert S Fisher; Jet Ho
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: in vitro/in vivo correlation.

Authors:  Satyanarayana Valiveti; Dana C Hammell; D Caroline Earles; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

7.  Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications.

Authors:  Sílvia S Guterres; Marta P Alves; Adriana R Pohlmann
Journal:  Drug Target Insights       Date:  2007-07-11

8.  Biodegradable In Situ Gel-Forming Controlled Drug Delivery System Based on Thermosensitive Poly(ε-caprolactone)-Poly(ethylene glycol)-Poly(ε-caprolactone) Hydrogel.

Authors:  Elham Khodaverdi; Ali Golmohammadian; Seyed Ahmad Mohajeri; Gholamhossein Zohuri; Farnaz Sadat Mirzazadeh Tekie; Farzin Hadizadeh
Journal:  ISRN Pharm       Date:  2012-11-27

9.  Dendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenac.

Authors:  Bin Huang; Wei-Jiang Dong; Gao-Yi Yang; Wei Wang; Cong-Hua Ji; Fei-Ni Zhou
Journal:  Drug Des Devel Ther       Date:  2015-07-23       Impact factor: 4.162

10.  Mathematical modeling of the release of active ingredients from a contraceptive patch: ortho evra(®) as a case study.

Authors:  Grissel Trujillo-de Santiago; Carlos Patricio Sáenz-Collins; Lizette García-Arellano; Mario Moisés Álvarez
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.